These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 31417563)

  • 1. Overexpression of PDE4A Acts as Checkpoint Inhibitor Against cAMP-Mediated Immunosuppression
    Schmetterer KG; Goldhahn K; Ziegler LS; Gerner MC; Schmidt RLJ; Themanns M; Zebedin-Brandl E; Trapin D; Leitner J; Pickl WF; Steinberger P; Schwarzinger I; Marculescu R
    Front Immunol; 2019; 10():1790. PubMed ID: 31417563
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Challenge of human Jurkat T-cells with the adenylate cyclase activator forskolin elicits major changes in cAMP phosphodiesterase (PDE) expression by up-regulating PDE3 and inducing PDE4D1 and PDE4D2 splice variants as well as down-regulating a novel PDE4A splice variant.
    Erdogan S; Houslay MD
    Biochem J; 1997 Jan; 321 ( Pt 1)(Pt 1):165-75. PubMed ID: 9003416
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inhibition of cAMP degradation improves regulatory T cell-mediated suppression.
    Bopp T; Dehzad N; Reuter S; Klein M; Ullrich N; Stassen M; Schild H; Buhl R; Schmitt E; Taube C
    J Immunol; 2009 Apr; 182(7):4017-24. PubMed ID: 19299699
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Phosphodiesterase 4A confers resistance to PGE2-mediated suppression in CD25
    Chen Z; Yang Y; Neo SY; Shi H; Chen Y; Wagner AK; Larsson K; Tong L; Jakobsson PJ; Alici E; Wu J; Cao Y; Wang K; Liu LL; Mao Y; Sarhan D; Lundqvist A
    EMBO Rep; 2021 Mar; 22(3):e51329. PubMed ID: 33480074
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Regulation of PD-L1 expression is a novel facet of cyclic-AMP-mediated immunosuppression.
    Sasi B; Ethiraj P; Myers J; Lin AP; Jiang S; Qiu Z; Holder KN; Aguiar RCT
    Leukemia; 2021 Jul; 35(7):1990-2001. PubMed ID: 33299141
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prostaglandin E2 induces the expression of functional inhibitory CD94/NKG2A receptors in human CD8+ T lymphocytes by a cAMP-dependent protein kinase A type I pathway.
    Zeddou M; Greimers R; de Valensart N; Nayjib B; Tasken K; Boniver J; Moutschen M; Rahmouni S
    Biochem Pharmacol; 2005 Sep; 70(5):714-24. PubMed ID: 15978547
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Phosphodiesterase-4 promotes proliferation and angiogenesis of lung cancer by crosstalk with HIF.
    Pullamsetti SS; Banat GA; Schmall A; Szibor M; Pomagruk D; Hänze J; Kolosionek E; Wilhelm J; Braun T; Grimminger F; Seeger W; Schermuly RT; Savai R
    Oncogene; 2013 Feb; 32(9):1121-34. PubMed ID: 22525277
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Type 4A cAMP-specific phosphodiesterase is stored in granules of human neutrophils and eosinophils.
    Pryzwansky KB; Madden VJ
    Cell Tissue Res; 2003 Jun; 312(3):301-11. PubMed ID: 12764607
    [TBL] [Abstract][Full Text] [Related]  

  • 9. microRNA-142-mediated repression of phosphodiesterase 3B critically regulates peripheral immune tolerance.
    Anandagoda N; Willis JC; Hertweck A; Roberts LB; Jackson I; Gökmen MR; Jenner RG; Howard JK; Lord GM
    J Clin Invest; 2019 Mar; 129(3):1257-1271. PubMed ID: 30741720
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Regulatory T-cells and cAMP suppress effector T-cells independently of PKA-CREM/ICER: a potential role for Epac.
    Vang AG; Housley W; Dong H; Basole C; Ben-Sasson SZ; Kream BE; Epstein PM; Clark RB; Brocke S
    Biochem J; 2013 Dec; 456(3):463-73. PubMed ID: 24007532
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The role of cyclic adenosine monophosphate in the suppression of cellular immunity after thermal injury.
    Horgan AF; O'Riordain DS; Chin DH; Mannick JA; Rodrick ML
    Arch Surg; 1994 Dec; 129(12):1284-9. PubMed ID: 7986157
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identification of substrate specificity determinants in human cAMP-specific phosphodiesterase 4A by single-point mutagenesis.
    Richter W; Unciuleac L; Hermsdorf T; Kronbach T; Dettmer D
    Cell Signal; 2001 Mar; 13(3):159-67. PubMed ID: 11282454
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Role of AKAP 149-PKA-PDE4A complex in cell survival and cell differentiation processes.
    Fernández-Araujo A; Tobío A; Alfonso A; Botana LM
    Int J Biochem Cell Biol; 2014 Aug; 53():89-101. PubMed ID: 24813785
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The role of the adenosinergic pathway in immunosuppression mediated by human regulatory T cells (Treg).
    Whiteside TL; Mandapathil M; Schuler P
    Curr Med Chem; 2011; 18(34):5217-23. PubMed ID: 22087822
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Upregulation of CD94 on CD8+T cells in anterior chamber-associated immune deviation.
    He H; Yang P; Jiang L; Zhang J; Zhao C; Chen L; Lin X; Zhou H; Kijlstra A
    BMC Immunol; 2008 Sep; 9():53. PubMed ID: 18816417
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mechanism of prostaglandin (PG)E2-induced prolactin expression in human T cells: cooperation of two PGE2 receptor subtypes, E-prostanoid (EP) 3 and EP4, via calcium- and cyclic adenosine 5'-monophosphate-mediated signaling pathways.
    Gerlo S; Verdood P; Gellersen B; Hooghe-Peters EL; Kooijman R
    J Immunol; 2004 Nov; 173(10):5952-62. PubMed ID: 15528329
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prostaglandin E2 acts at two distinct pathways of T lymphocyte activation: inhibition of interleukin 2 production and down-regulation of transferrin receptor expression.
    Chouaib S; Welte K; Mertelsmann R; Dupont B
    J Immunol; 1985 Aug; 135(2):1172-9. PubMed ID: 2989362
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Maturation of human monocyte-derived dendritic cells (MoDCs) in the presence of prostaglandin E2 optimizes CD4 and CD8 T cell-mediated responses to protein antigens: role of PGE2 in chemokine and cytokine expression by MoDCs.
    Rubio MT; Means TK; Chakraverty R; Shaffer J; Fudaba Y; Chittenden M; Luster AD; Sykes M
    Int Immunol; 2005 Dec; 17(12):1561-72. PubMed ID: 16303787
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In vitro and in vivo activated T cells display increased sensitivity to PGE2.
    Sunder-Plassmann R; Majdic O; Knapp W; Holter W
    Cell Immunol; 1991 Dec; 138(2):289-99. PubMed ID: 1657408
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Modulation of regulatory T cell function by monocyte-derived dendritic cells matured through electroporation with mRNA encoding CD40 ligand, constitutively active TLR4, and CD70.
    Pen JJ; De Keersmaecker B; Maenhout SK; Van Nuffel AM; Heirman C; Corthals J; Escors D; Bonehill A; Thielemans K; Breckpot K; Aerts JL
    J Immunol; 2013 Aug; 191(4):1976-83. PubMed ID: 23842750
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.